Also published in Stock Market Today:
TriMas Wins 2012 Award For Governance
x hide permanently

Gilead Sciences Names Roche's O'Day as CEO and Chairman

Stock Market Today

Biopharmaceutical giant Gilead Sciences Inc. named Daniel O'Day, who heads Roche Holding AG's pharmaceuticals business, as its next CEO.  The California-based company's board...

Mentions: Gilead Sciences California Daniel O'Day